newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

genai / news / / TechStartups.com

OpenEvidence closed a $200 million Series C to scale its AI medical platform reach.

OpenEvidence raised $200 million Series C at a $6 billion valuation to scale medical AI.

KEY POINTS
COMPANIES
Read the full story on TechStartups.com →
Share X LinkedIn

Summarized by Newsio from TechStartups.com. How we summarize →